Evaluation of the anti-proliferative activity of three new pyrazole compounds in sensitive and resistant tumor cell lines

Maurizio Viale, Maria Anzaldi, Cinzia Aiello, Carla Fenoglio, Federica Albicini, Laura Emionite, Rosaria Gangemi, Alessandro Balbi

Research output: Contribution to journalArticlepeer-review

Abstract

Background: In previous papers we demonstrated that the activity of short heteroretinoids as anti-proliferative and pro-apoptotic compounds was deeply linked to their heterocyclic moiety and that ionone-derived 1,5-pyrazoles had the highest anti-proliferative activity in our preliminary experiments. We then demonstrated the high and pharmacologically significant anti-proliferative and apoptotic activities of the pyrazole compounds 2-(1-(4-chlorophenyl)-1H-pyrazol- 5-yl)-5-methoxyphenol (EN12-4), 5-methoxy- 2-(1-(pyridin-2-yl)-1H-pyrazol-5-yl) phenol (EN12-2A) and 2-(5-(4-methoxyphenyl)-1H-pyrazol-1-yl)pyridine (EN7-2) establishing, especially for EN12-2A, a possible mechanism of action involving the cell microtubular system. Methods: Here, the anti-proliferative activity of these pyrazole compounds was analyzed in vitro by the MTT assay in six drugresistant cell lines, five of which were selected after exposure to increasing concentrationsof cisplatin (L1210/DDP), doxorubicin (A2780/DX3), 5-fluorouracil (HCT-8/5FU), taxol (A549/T24) and etoposide (MCF-7/VP), and one was obtained by transfection of the ABCG2 membrane transporter (HEK-293/R2). Results: Our data show that these compounds have a similar anti-proliferative activity in nearly all resistant and sensitive cell lines, demonstrating their ability to overcome the most common mechanisms of drug resistance with two exceptions regarding the MCF-7/VP cell line over-expressing the ABCC1 (MRP1) transporter, and the MDR1 over-expressing A2780/DX3 cells, with a calculated RI = 3.2 for EN12-2A, relative to their sensitive cellular counterpart. On the other hand, the taxol-resistant A549/T24 cell line showed a significantly increased sensitivity to our compounds. Conclusions: Our data suggest that our pyrazole compounds are able to overcome in vitro the most common drug-resistance mechanisms demonstrating a significant anti-proliferative activity and confirming a mechanism of action involving the depolymerization ofmicrotubules.

Original languageEnglish
Pages (from-to)717-723
Number of pages7
JournalPharmacological Reports
Volume65
Issue number3
Publication statusPublished - 2013

Keywords

  • Anti-proliferative activity
  • Drug-resistance mechanisms
  • Pyrazole compounds

ASJC Scopus subject areas

  • Pharmacology

Fingerprint Dive into the research topics of 'Evaluation of the anti-proliferative activity of three new pyrazole compounds in sensitive and resistant tumor cell lines'. Together they form a unique fingerprint.

Cite this